News and Announcements
Nvoi (ASX: NVO) Signs First Corporate Client, Integrated Research
- Published June 27, 2017 12:00AM UTC
- Publisher Wholesale Investor
- Categories Company Updates
Nvoi is pleased to announce Integrated Research as a new Corporate Client on the Nvoi digital platform. This comes just three months after Nvoi launched its enhanced end to end platform.
KEY TAKEAWAYS:
- Integrated Research has commenced listing a number of pilot active roles.
- Nvoi will work with Integrated Research to optimise platform processes to deliver corporate client expectations.
- This model of piloting roles, and then expanding, is being offered to all corporate clients to help transition them from the traditional manual process to Nvoi’s digital self-service approach.
- Nvoi’s dual strategy of strategic account focus and scaling SME’s, continues to drive month on month revenue growth with strong progress between March and June.
- Appointment of Oliver Spiers as Nvoi’s Head of Sales.
Heidi Newbury, Director of HR for Integrated Research, says “In support of delivering on our growth strategy, working with Nvoi opened up new avenues for obtaining skills in a simple to use, cost effective process.”
Company Updates
500 Million Episodes, Limited Treatment: How Patrys is Bridging the Gap in an Underserved Market
In the clinical vocabulary of the Intensive Care Unit, there is perhaps no word that carries as much quiet dread as delirium. It is a “chemical storm” of the brain—an acute dysfunction where the delicate balance between calming and activating signals is scrambled. For the patient, it can be a waking nightmare of hallucinations and […]
The Light Fantastic: Why Invion’s Photodynamic Therapy May Be Attracting Big Pharma’s Attention
Invion Limited is challenging the status quo in oncology with its Photosoft™ platform, a precision therapy that uses light-activated molecules to selectively target cancer cells. By transforming the body’s own immune response and addressing the high costs of current cancer treatments, Invion is positioning itself as a transformative player in the biotech sector. With clinical trials underway and strong institutional partnerships, the company is bridging the gap between scientific breakthrough and accessible, scalable patient care.
From Outback to Boardroom: How SWAN Systems is Codifying Water Stewardship
From the arid deserts of Australia to the boardrooms of global tech giants, SWAN Systems is redefining water efficiency. By bridging the gap between field-level agronomics and autonomous irrigation control, the company is proving that “water-positive” targets can be met with science, data, and a 10x ROI commitment.
Backed By Leading Investment Groups and Family Offices
